Processa Pharmaceuticals, Inc. (PCSA)
2.27
-0.11
(-4.62%)
USD |
NASDAQ |
Feb 09, 16:00
2.27
0.00 (0.00%)
After-Hours: 20:00
Processa Pharmaceuticals EPS Diluted (Quarterly) : -1.808 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | -1.163 |
| Pyxis Oncology, Inc. | -0.3517 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.437M |
| Total Expenses (Quarterly) | 3.437M |
| Enterprise Value | -0.9158M |
| Earnings Yield | -1.18K% |
| Normalized Earnings Yield | -1183.94 |